![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 35/17 | (2015.01) |
C12N 15/113 | (2013.01) | ||
A61P 35/02 | (2006.01) | ||
C12N2310/20 | (2017.05) | ||
C07K 14/70503 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 14/70521 | (2013.01) | ||
A61P 31/12 | (2006.01) | ||
C07K 14/715 | (2006.01) | ||
C07K 14/4703 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
A61K 35/17 | (2013.01) | ||
C07K 14/47 | (2006.01) | ||
A61P 31/00 | (2018.01) | ||
C12N 9/22 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
C12N 15/113 | (2010.01) | ||
C07K 14/7158 | (2013.01) | ||
A61P 31/00 | (2006.01) | ||
C12N 9/22 | (2013.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 31/12 | (2018.01) |
(11) | Number of the document | 3529359 |
(13) | Kind of document | T |
(96) | European patent application number | 17861792.4 |
Date of filing the European patent application | 2017-10-18 | |
(97) | Date of publication of the European application | 2019-08-28 |
(45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/057228 |
Date | 2017-10-18 |
(87) | Number | WO 2018/075664 |
Date | 2018-04-26 |
(30) | Number | Date | Country code |
201662409651 P | 2016-10-18 | US | |
201762452244 P | 2017-01-30 | US |
(72) |
MORIARITY, Branden , US
WEBBER, Beau , US
CHOUDHRY, Modassir , US
ROSENBERG, Steven A. , US
PALMER, Douglas C. , US
RESTIFO, Nicholas P. , US
|
(73) |
Regents of the University of Minnesota ,
600 McNamara Alumni Center
200 Oak Street S.E., Minneapolis, MN 55455-2020,
US
Intima Bioscience, Inc. , 3 Columbus Circle, New York, New York 10019, US The United States of America, as represented by the Secretary, Department of Health and Human Services , Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, US |
(54) | TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY |
TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY |